Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_single_gel_8d.class.cls #double_gel_8d_versus_single_gel_8d_repos |
Phenotype | class.cls#double_gel_8d_versus_single_gel_8d_repos |
Upregulated in class | double_gel_8d |
GeneSet | INFLAMMATORY_RESPONSE |
Enrichment Score (ES) | 0.46714604 |
Normalized Enrichment Score (NES) | 1.7116191 |
Nominal p-value | 0.0 |
FDR q-value | 0.029656613 |
FWER p-Value | 0.997 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | TNFAIP6 | TNFAIP6 Entrez,  Source | tumor necrosis factor, alpha-induced protein 6 | 64 | 0.710 | 0.0488 | Yes |
2 | CDO1 | CDO1 Entrez,  Source | cysteine dioxygenase, type I | 104 | 0.612 | 0.0921 | Yes |
3 | CCL20 | CCL20 Entrez,  Source | chemokine (C-C motif) ligand 20 | 166 | 0.509 | 0.1260 | Yes |
4 | MGLL | MGLL Entrez,  Source | monoglyceride lipase | 241 | 0.443 | 0.1539 | Yes |
5 | MBL2 | MBL2 Entrez,  Source | mannose-binding lectin (protein C) 2, soluble (opsonic defect) | 263 | 0.424 | 0.1844 | Yes |
6 | CXCL2 | CXCL2 Entrez,  Source | chemokine (C-X-C motif) ligand 2 | 267 | 0.421 | 0.2159 | Yes |
7 | FOS | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 299 | 0.398 | 0.2437 | Yes |
8 | CXCL1 | CXCL1 Entrez,  Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 309 | 0.392 | 0.2726 | Yes |
9 | CFHR1 | CFHR1 Entrez,  Source | complement factor H-related 1 | 350 | 0.362 | 0.2970 | Yes |
10 | CCL3 | CCL3 Entrez,  Source | chemokine (C-C motif) ligand 3 | 447 | 0.321 | 0.3140 | Yes |
11 | TPST1 | TPST1 Entrez,  Source | tyrosylprotein sulfotransferase 1 | 453 | 0.319 | 0.3377 | Yes |
12 | CRP | CRP Entrez,  Source | C-reactive protein, pentraxin-related | 534 | 0.289 | 0.3535 | Yes |
13 | CD40 | CD40 Entrez,  Source | CD40 molecule, TNF receptor superfamily member 5 | 586 | 0.271 | 0.3701 | Yes |
14 | LBP | LBP Entrez,  Source | lipopolysaccharide binding protein | 701 | 0.238 | 0.3796 | Yes |
15 | KLRG1 | KLRG1 Entrez,  Source | killer cell lectin-like receptor subfamily G, member 1 | 729 | 0.233 | 0.3951 | Yes |
16 | ALOX5AP | ALOX5AP Entrez,  Source | arachidonate 5-lipoxygenase-activating protein | 764 | 0.225 | 0.4095 | Yes |
17 | CEBPB | CEBPB Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), beta | 862 | 0.212 | 0.4182 | Yes |
18 | IRAK2 | IRAK2 Entrez,  Source | interleukin-1 receptor-associated kinase 2 | 868 | 0.212 | 0.4338 | Yes |
19 | SIGIRR | SIGIRR Entrez,  Source | single immunoglobulin and toll-interleukin 1 receptor (TIR) domain | 872 | 0.211 | 0.4496 | Yes |
20 | IL1RAP | IL1RAP Entrez,  Source | interleukin 1 receptor accessory protein | 1037 | 0.188 | 0.4514 | Yes |
21 | CD40LG | CD40LG Entrez,  Source | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | 1443 | 0.154 | 0.4324 | Yes |
22 | CD97 | CD97 Entrez,  Source | CD97 molecule | 1481 | 0.151 | 0.4411 | Yes |
23 | ADORA1 | ADORA1 Entrez,  Source | adenosine A1 receptor | 1508 | 0.149 | 0.4503 | Yes |
24 | IL8RA | IL8RA Entrez,  Source | interleukin 8 receptor, alpha | 1575 | 0.144 | 0.4563 | Yes |
25 | C3AR1 | C3AR1 Entrez,  Source | complement component 3a receptor 1 | 1576 | 0.144 | 0.4671 | Yes |
26 | CXCL9 | CXCL9 Entrez,  Source | chemokine (C-X-C motif) ligand 9 | 1860 | 0.128 | 0.4555 | No |
27 | TNFRSF1A | TNFRSF1A Entrez,  Source | tumor necrosis factor receptor superfamily, member 1A | 1920 | 0.125 | 0.4605 | No |
28 | CCR1 | CCR1 Entrez,  Source | chemokine (C-C motif) receptor 1 | 2108 | 0.117 | 0.4553 | No |
29 | ADORA3 | ADORA3 Entrez,  Source | adenosine A3 receptor | 2254 | 0.112 | 0.4528 | No |
30 | TACR1 | TACR1 Entrez,  Source | tachykinin receptor 1 | 2454 | 0.105 | 0.4457 | No |
31 | CCL11 | CCL11 Entrez,  Source | chemokine (C-C motif) ligand 11 | 2556 | 0.101 | 0.4457 | No |
32 | APCS | APCS Entrez,  Source | amyloid P component, serum | 2625 | 0.098 | 0.4480 | No |
33 | CCL5 | CCL5 Entrez,  Source | chemokine (C-C motif) ligand 5 | 2781 | 0.092 | 0.4433 | No |
34 | ADORA2A | ADORA2A Entrez,  Source | adenosine A2a receptor | 3051 | 0.083 | 0.4293 | No |
35 | ORM1 | ORM1 Entrez,  Source | orosomucoid 1 | 3328 | 0.075 | 0.4141 | No |
36 | GHSR | GHSR Entrez,  Source | growth hormone secretagogue receptor | 3367 | 0.074 | 0.4169 | No |
37 | CCL22 | CCL22 Entrez,  Source | chemokine (C-C motif) ligand 22 | 3377 | 0.074 | 0.4218 | No |
38 | PLA2G2D | PLA2G2D Entrez,  Source | phospholipase A2, group IID | 3584 | 0.069 | 0.4115 | No |
39 | NFKB1 | NFKB1 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 3646 | 0.068 | 0.4120 | No |
40 | IL1A | IL1A Entrez,  Source | interleukin 1, alpha | 3784 | 0.064 | 0.4065 | No |
41 | AIF1 | AIF1 Entrez,  Source | allograft inflammatory factor 1 | 3839 | 0.063 | 0.4072 | No |
42 | NMI | NMI Entrez,  Source | N-myc (and STAT) interactor | 4163 | 0.056 | 0.3871 | No |
43 | ABCF1 | ABCF1 Entrez,  Source | ATP-binding cassette, sub-family F (GCN20), member 1 | 4274 | 0.053 | 0.3828 | No |
44 | HDAC5 | HDAC5 Entrez,  Source | histone deacetylase 5 | 4333 | 0.052 | 0.3824 | No |
45 | CHRNA7 | CHRNA7 Entrez,  Source | cholinergic receptor, nicotinic, alpha 7 | 4725 | 0.043 | 0.3561 | No |
46 | ALOX15 | ALOX15 Entrez,  Source | arachidonate 15-lipoxygenase | 4728 | 0.043 | 0.3592 | No |
47 | AOC3 | AOC3 Entrez,  Source | amine oxidase, copper containing 3 (vascular adhesion protein 1) | 4870 | 0.040 | 0.3517 | No |
48 | LTB4R | LTB4R Entrez,  Source | leukotriene B4 receptor | 4960 | 0.039 | 0.3479 | No |
49 | ELF3 | ELF3 Entrez,  Source | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 5014 | 0.038 | 0.3467 | No |
50 | PRDX5 | PRDX5 Entrez,  Source | peroxiredoxin 5 | 5059 | 0.037 | 0.3462 | No |
51 | IL13 | IL13 Entrez,  Source | interleukin 13 | 5064 | 0.037 | 0.3487 | No |
52 | S100A9 | S100A9 Entrez,  Source | S100 calcium binding protein A9 | 5107 | 0.036 | 0.3482 | No |
53 | CXCL10 | CXCL10 Entrez,  Source | chemokine (C-X-C motif) ligand 10 | 5128 | 0.035 | 0.3493 | No |
54 | NFX1 | NFX1 Entrez,  Source | nuclear transcription factor, X-box binding 1 | 5152 | 0.035 | 0.3503 | No |
55 | CXCR4 | CXCR4 Entrez,  Source | chemokine (C-X-C motif) receptor 4 | 5204 | 0.034 | 0.3490 | No |
56 | IL5 | IL5 Entrez,  Source | interleukin 5 (colony-stimulating factor, eosinophil) | 5207 | 0.034 | 0.3514 | No |
57 | AGER | AGER Entrez,  Source | advanced glycosylation end product-specific receptor | 5500 | 0.028 | 0.3314 | No |
58 | IL8RB | IL8RB Entrez,  Source | interleukin 8 receptor, beta | 5537 | 0.027 | 0.3308 | No |
59 | NFATC4 | NFATC4 Entrez,  Source | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | 5709 | 0.024 | 0.3196 | No |
60 | CCR5 | CCR5 Entrez,  Source | chemokine (C-C motif) receptor 5 | 5806 | 0.022 | 0.3141 | No |
61 | CCR2 | CCR2 Entrez,  Source | chemokine (C-C motif) receptor 2 | 5861 | 0.021 | 0.3116 | No |
62 | SCG2 | SCG2 Entrez,  Source | secretogranin II (chromogranin C) | 6564 | 0.007 | 0.2591 | No |
63 | NOX4 | NOX4 Entrez,  Source | NADPH oxidase 4 | 6694 | 0.004 | 0.2497 | No |
64 | MEFV | MEFV Entrez,  Source | Mediterranean fever | 7026 | -0.003 | 0.2249 | No |
65 | CCR3 | CCR3 Entrez,  Source | chemokine (C-C motif) receptor 3 | 7177 | -0.006 | 0.2140 | No |
66 | AHSG | AHSG Entrez,  Source | alpha-2-HS-glycoprotein | 7259 | -0.008 | 0.2085 | No |
67 | RELA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 7310 | -0.008 | 0.2054 | No |
68 | CCR4 | CCR4 Entrez,  Source | chemokine (C-C motif) receptor 4 | 7502 | -0.012 | 0.1919 | No |
69 | CCL4 | CCL4 Entrez,  Source | chemokine (C-C motif) ligand 4 | 7592 | -0.014 | 0.1863 | No |
70 | F11R | F11R Entrez,  Source | F11 receptor | 8090 | -0.025 | 0.1507 | No |
71 | AOX1 | AOX1 Entrez,  Source | aldehyde oxidase 1 | 8449 | -0.033 | 0.1262 | No |
72 | CYBB | CYBB Entrez,  Source | cytochrome b-245, beta polypeptide (chronic granulomatous disease) | 8513 | -0.035 | 0.1240 | No |
73 | GHRL | GHRL Entrez,  Source | ghrelin/obestatin preprohormone | 8739 | -0.040 | 0.1101 | No |
74 | PTAFR | PTAFR Entrez,  Source | platelet-activating factor receptor | 9097 | -0.049 | 0.0868 | No |
75 | PARP4 | PARP4 Entrez,  Source | poly (ADP-ribose) polymerase family, member 4 | 9368 | -0.056 | 0.0707 | No |
76 | RAC1 | RAC1 Entrez,  Source | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 9885 | -0.071 | 0.0371 | No |
77 | HRH1 | HRH1 Entrez,  Source | histamine receptor H1 | 9893 | -0.071 | 0.0420 | No |
78 | SELE | SELE Entrez,  Source | selectin E (endothelial adhesion molecule 1) | 9951 | -0.073 | 0.0432 | No |
79 | S100A8 | S100A8 Entrez,  Source | S100 calcium binding protein A8 | 10280 | -0.084 | 0.0248 | No |
80 | RIPK2 | RIPK2 Entrez,  Source | receptor-interacting serine-threonine kinase 2 | 10507 | -0.092 | 0.0147 | No |
81 | SCYE1 | SCYE1 Entrez,  Source | small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating) | 10959 | -0.110 | -0.0111 | No |
82 | CX3CL1 | CX3CL1 Entrez,  Source | chemokine (C-X3-C motif) ligand 1 | 11035 | -0.114 | -0.0081 | No |
83 | LYZ | LYZ Entrez,  Source | lysozyme (renal amyloidosis) | 11060 | -0.115 | -0.0013 | No |
84 | C2 | C2 Entrez,  Source | complement component 2 | 11264 | -0.125 | -0.0072 | No |
85 | BLNK | BLNK Entrez,  Source | B-cell linker | 11704 | -0.150 | -0.0290 | No |
86 | HDAC7A | HDAC7A Entrez,  Source | histone deacetylase 7A | 12032 | -0.176 | -0.0404 | No |
87 | CXCL11 | CXCL11 Entrez,  Source | chemokine (C-X-C motif) ligand 11 | 12838 | -0.299 | -0.0785 | No |
88 | TGFB1 | TGFB1 Entrez,  Source | transforming growth factor, beta 1 (Camurati-Engelmann disease) | 13047 | -0.395 | -0.0644 | No |
89 | ANXA1 | ANXA1 Entrez,  Source | annexin A1 | 13327 | -1.146 | 0.0011 | No |